-
1
-
-
77649322365
-
Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients
-
Wu CH, Fan WC, Chen YM, Chou KT, Shih JF, Tsai CM, et al: Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients. J Thorac Oncol 5: 376-379, 2010.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 376-379
-
-
Wu, C.H.1
Fan, W.C.2
Chen, Y.M.3
Chou, K.T.4
Shih, J.F.5
Tsai, C.M.6
-
2
-
-
61449150588
-
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
-
Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, et al: Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 64: 92-97, 2009.
-
(2009)
Lung Cancer
, vol.64
, pp. 92-97
-
-
Paci, M.1
Maramotti, S.2
Bellesia, E.3
Formisano, D.4
Albertazzi, L.5
Ricchetti, T.6
-
3
-
-
33749128507
-
Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool
-
Pathak AK, Bhutani M, Kumar S, Mohan A and Guleria R: Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52: 1833-1842, 2006.
-
(2006)
Clin Chem
, vol.52
, pp. 1833-1842
-
-
Pathak, A.K.1
Bhutani, M.2
Kumar, S.3
Mohan, A.4
Guleria, R.5
-
4
-
-
58549084394
-
Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy
-
Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I and Inoue T: Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci 100: 303-309, 2009.
-
(2009)
Cancer Sci
, vol.100
, pp. 303-309
-
-
Cheng, C.1
Omura-Minamisawa, M.2
Kang, Y.3
Hara, T.4
Koike, I.5
Inoue, T.6
-
5
-
-
0030792850
-
Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line
-
Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB and Hockenbery DM: Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 138: 449-469, 1997.
-
(1997)
J Cell Biol
, vol.138
, pp. 449-469
-
-
Mancini, M.1
Anderson, B.O.2
Caldwell, E.3
Sedghinasab, M.4
Paty, P.B.5
Hockenbery, D.M.6
-
6
-
-
48749131866
-
Mitochondrial DNA in serum of patients with prostate cancer: A predictor of biochemical recurrence after prostatectomy
-
Ellinger J, Müller SC, Wernert N, von Ruecker A and Bastian PJ: Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy. BJU Int 102: 628-632, 2008.
-
(2008)
BJU Int
, vol.102
, pp. 628-632
-
-
Ellinger, J.1
Müller, S.C.2
Wernert, N.3
von Ruecker, A.4
Bastian, P.J.5
-
7
-
-
77954143056
-
Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis
-
Zhang R, Shao F, Wu X and Ying K: Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis. Lung Cancer 69: 225-231, 2010.
-
(2010)
Lung Cancer
, vol.69
, pp. 225-231
-
-
Zhang, R.1
Shao, F.2
Wu, X.3
Ying, K.4
-
8
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
-
Eisenhauer EA, Therasse P, Bogaerts J, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009.
-
(2009)
Eur J Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
-
9
-
-
0035040809
-
Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer
-
Vassilakopoulos T, Troupis T, Sotiropoulou C, Zacharatos P, Katsaounou P, Parthenis D, et al: Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 32: 137-144, 2001.
-
(2001)
Lung Cancer
, vol.32
, pp. 137-144
-
-
Vassilakopoulos, T.1
Troupis, T.2
Sotiropoulou, C.3
Zacharatos, P.4
Katsaounou, P.5
Parthenis, D.6
-
10
-
-
14744275382
-
Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer
-
Suemitsu R, Yoshino I, Tomiyasu M, Fukuyama S, Okamoto T and Maehara Y: Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer. Surg Today 34: 896-901, 2004.
-
(2004)
Surg Today
, vol.34
, pp. 896-901
-
-
Suemitsu, R.1
Yoshino, I.2
Tomiyasu, M.3
Fukuyama, S.4
Okamoto, T.5
Maehara, Y.6
-
11
-
-
0036841417
-
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
-
Kulpa J, Wójcik E, Reinfuss M and Kolodziejski L: Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 48: 1931-1937, 2002.
-
(2002)
Clin Chem
, vol.48
, pp. 1931-1937
-
-
Kulpa, J.1
Wójcik, E.2
Reinfuss, M.3
Kolodziejski, L.4
-
12
-
-
0035875037
-
Analysis of circulating DNA in plasma at diagnosis and during follow-up of lung cancer patients
-
Sozzi G, Conte D, Mariani L, et al: Analysis of circulating DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61: 4675-4678, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 4675-4678
-
-
Sozzi, G.1
Conte, D.2
Mariani, L.3
-
13
-
-
0642311916
-
Quantification of free circulating DNA as a diagnostic marker in lung cancer
-
Sozzi G, Conte D, Leon M, et al: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908, 2003.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3902-3908
-
-
Sozzi, G.1
Conte, D.2
Leon, M.3
-
14
-
-
1942469436
-
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
-
Gai S, Fidler C, Lo YM, et al: Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 90: 1211-1215, 2004.
-
(2004)
Br J Cancer
, vol.90
, pp. 1211-1215
-
-
Gai, S.1
Fidler, C.2
Lo, Y.M.3
-
15
-
-
33845805706
-
Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer
-
Flamini E, Mercatali L, Nanni O, et al: Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 12: 6985-6988, 2006.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6985-6988
-
-
Flamini, E.1
Mercatali, L.2
Nanni, O.3
-
17
-
-
34248569300
-
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
-
Gormally E, Caboux E, Vineis P and Hainaut P: Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635: 105-117, 2007.
-
(2007)
Mutat Res
, vol.635
, pp. 105-117
-
-
Gormally, E.1
Caboux, E.2
Vineis, P.3
Hainaut, P.4
-
18
-
-
7644221210
-
Extracellular circulating nucleic acids in human plasma in health and disease
-
Laktionov PP, Tamkovich SN, Rykova EY, Bryzgunova OE, Starikov AV, Kuznetsova NP, et al: Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucleic Acids 23: 879-883, 2004.
-
(2004)
Nucleosides Nucleotides Nucleic Acids
, vol.23
, pp. 879-883
-
-
Laktionov, P.P.1
Tamkovich, S.N.2
Rykova, E.Y.3
Bryzgunova, O.E.4
Starikov, A.V.5
Kuznetsova, N.P.6
-
19
-
-
33749583840
-
Cell-free DNA levels as a prognostic marker in acute myocardial infarction
-
Antonatos D, Patsilinakos S, Spanodimos S, Korkonikitas P and Tsigas D: Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann NY Acad Sci 1075: 278-281, 2006.
-
(2006)
Ann NY Acad Sci
, vol.1075
, pp. 278-281
-
-
Antonatos, D.1
Patsilinakos, S.2
Spanodimos, S.3
Korkonikitas, P.4
Tsigas, D.5
-
20
-
-
33749128507
-
Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool
-
Pathak AK, Bhutani M, Kumar S, Mohan A and Guleria R: Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52: 1833-1842, 2006.
-
(2006)
Clin Chem
, vol.52
, pp. 1833-1842
-
-
Pathak, A.K.1
Bhutani, M.2
Kumar, S.3
Mohan, A.4
Guleria, R.5
-
21
-
-
84857502654
-
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
-
Rosell R, Carcereny E, Gervais R, et al: Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13: 239-246, 2012.
-
(2012)
Lancet Oncol
, vol.13
, pp. 239-246
-
-
Rosell, R.1
Carcereny, E.2
Gervais, R.3
-
22
-
-
84859813987
-
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
-
Punnoose EA, Atwal S, Liu W, et al: Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18: 2391-2401, 2012.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 2391-2401
-
-
Punnoose, E.A.1
Atwal, S.2
Liu, W.3
-
24
-
-
17944367327
-
Mitochondrial mutations in early stage prostate cancer and bodily fluids
-
Jerónimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, et al: Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20: 5195-5198, 2001.
-
(2001)
Oncogene
, vol.20
, pp. 5195-5198
-
-
Jerónimo, C.1
Nomoto, S.2
Caballero, O.L.3
Usadel, H.4
Henrique, R.5
Varzim, G.6
-
25
-
-
0017360626
-
Free DNA in the serum of cancer patients and the effect of therapy
-
Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977.
-
(1977)
Cancer Res
, vol.37
, pp. 646-650
-
-
Leon, S.A.1
Shapiro, B.2
Sklaroff, D.M.3
Yaros, M.J.4
-
26
-
-
77956487870
-
Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer
-
Kumar S, Guleria R, Singh V, et al: Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer. Eur Respir J 36: 885-892, 2010.
-
(2010)
Eur Respir J
, vol.36
, pp. 885-892
-
-
Kumar, S.1
Guleria, R.2
Singh, V.3
|